Evidence map›Paper›PMID 40622779›Full record

ReviewChemical reviews2025

Medical and Nonmedical Applications of Synthetic Transmembrane Anion Transporters.

Uththara M C Rathnaweera, Surid Mohammad Chowdhury, Rayhanus Salam, Nathalie Busschaert

Abstract readReview
In one paragraph

Review in Chemical reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Lipophilic mono-guanidinesRSC advances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Near-Infrared Triggered Anion Transport Induces Cancer Cell Death.Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Uththara M C RathnaweeraDepartment of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.
Surid Mohammad ChowdhuryDepartment of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.
Rayhanus SalamDepartment of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.ORCID 0000-0002-3007-6108
Nathalie BusschaertDepartment of Chemistry, Tulane University, New Orleans, Louisiana 70118, United States.ORCID 0000-0002-3612-3382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transport of anionic species across phospholipid bilayers is an important biological function that plays a vital role in cellular and organismal homeostasis. The function is normally performed by transmembrane transport proteins, but several diseases have been linked to malfunctioning or malregulation of these proteins (so-called "channelopathies"). As a consequence, supramolecular chemists have tried to develop synthetic molecules that can transport anions across biological membranes. While the original goal of this endeavor was the development of potential therapeutics for channelopathies, it is now clear that there are several other potential medical and nonmedical applications for synthetic transmembrane anion transporters. The medical applications of synthetic anion transporters have been widely explored, especially their potential as anticancer agents. However, there are many other applications of synthetic anion transporters that are often overlooked. These range from antibacterial activity and drug delivery, to nonmedical applications such as biomimicry, the development of optical sensors, catalysis, organic synthesis and others. In this review, we aim to highlight the versatility of synthetic transmembrane anion transporters and to convince chemists to look beyond channelopathies and anticancer activity as applications of artificial anion transporters.

Indexed as

Anion Transport ProteinsAnimalsAnionsAnti-Bacterial AgentsAntineoplastic AgentsDrug Delivery SystemsHumansAnionsAnion Transport ProteinsAnti-Bacterial AgentsAntineoplastic Agents

Identifiers

PMID40622779
PMCPMC12426886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.